Healthcare -
Biotechnology - NASDAQ - US
$ 33.91
0.653 %
$ 3.78 B
Market Cap
-36.07
P/E
VKTX - INTEREST INCOME & EXPENSE
Interest Income & Expense VKTX - Viking Therapeutics, Inc.
88 K
LAST VALUE
121.11%
2 YEAR CAGR
-26.27%
5 YEAR CAGR
13.62%
10 YEAR CAGR